The Richardson Perspective

The biotech pioneering cellular rejuvenation just added the finance chief behind Spark's $4.3B sale to its board. It’s a clear sign the firm is preparing to scale.

Terra Clean Energy is using 3D modeling to resurrect a historic Utah mine, betting that digital analysis of old data can fuel America's new energy future.

Strive, Inc. reports a massive Q2 loss on paper, but a closer look reveals a debt-free company doubling down on Bitcoin and launching a daily dividend.

A massive earnings jump masks underlying operational costs. HEI leverages its wildfire settlement clarity to launch a huge renewable energy and grid hardening plan.

WM Technology's Q2 results show a puzzling split: higher net income but falling revenue and key metrics. Is this savvy cost-cutting or a sign of deeper trouble?

Artiva Biotherapeutics secures FDA fast-track status for its novel NK cell therapy, AlloNK. This could revolutionize autoimmune care for millions.

Apyx Medical's Q2 results show a 28% surge in its aesthetics unit, driven by the new AYON system. Is this strategic pivot away from OEM the key to its future?

As Intchains prepares its H1 2026 report, it's not just financials on the line. It's a test of a bold strategy to build a Web3 ecosystem beyond Bitcoin.

Facing financial headwinds, the energy storage firm's secret deal could be a brilliant strategic pivot or a desperate gambit for survival in a rapidly changing sector.

A new partnership between Japan's Ono Pharma and US biotech Mediar aims to disrupt the massive fibro-inflammatory disease market by targeting the root cell of scarring.

With a new $345 genome and major clinical wins, PacBio pushes boundaries. But can its strategic restructuring and bold R&D overcome mounting financial losses?

With a unique process for pristine graphene, HydroGraph heads to an elite investor conference, signaling a pivotal shift from R&D to industrial scale.

With a strategic investment from UMass Memorial Health, Wellinks is scaling its predictive tech to prevent crises before they start. A new model for chronic care.

CTG's top Microsoft partner rank isn't just an award; it's a critical guide for businesses seeking to turn AI potential into measurable results.

How did a Dallas firm secure a historic $7.37B verdict and a Hall of Fame honor? A look at Hamilton Wingo's system of trial readiness and peer respect.

A partnership between Trupanion and Digitail isn't just software. It's a blueprint for tackling veterinary burnout and revolutionizing pet healthcare access.

A sustainability award reveals a deeper strategy: investing $7.4M not just in chargers, but in community education and workforce development to build a market.

InfraTech Capital is betting big on the convergence of digital, energy, and real assets with a new European push. Is its 'operator's approach' the key?

The commercial cleaning industry faces a paradox: soaring demand and a shrinking workforce. A new analysis reveals the solution isn't cheaper tools, but smarter ones.

Nearly two decades after its parent's collapse, a Lehman entity plans its final act, putting a massive $19.6 billion claim on the market.